172 related articles for article (PubMed ID: 2974879)
21. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
Hall MD; Jenner P; Kelly E; Marsden CD
Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
[TBL] [Abstract][Full Text] [Related]
22. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
23. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
Battaglia G; Titeler M
Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
[TBL] [Abstract][Full Text] [Related]
24. Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.
Farde L; Pauli S; Hall H; Eriksson L; Halldin C; Högberg T; Nilsson L; Sjögren I; Stone-Elander S
Psychopharmacology (Berl); 1988; 94(4):471-8. PubMed ID: 3131792
[TBL] [Abstract][Full Text] [Related]
25. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.
Dubois A; Savasta M; Curet O; Scatton B
Neuroscience; 1986 Sep; 19(1):125-37. PubMed ID: 2946980
[TBL] [Abstract][Full Text] [Related]
26. Specific in vivo binding of 3H-spiperone to individual lobes of the pituitary gland of the rat. Evidence for the labelling of dopamine receptors.
Köhler C; Fahlberg K
J Neural Transm; 1985; 63(1):39-52. PubMed ID: 4031846
[TBL] [Abstract][Full Text] [Related]
27. Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
Fuxe K; Agnati LF; Köhler C; Kuonen D; Ogren SO; Andersson K; Hökfelt T
J Neural Transm; 1981; 51(1-2):3-37. PubMed ID: 7264628
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
[TBL] [Abstract][Full Text] [Related]
29. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
Ekman A; Eriksson E
Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955
[TBL] [Abstract][Full Text] [Related]
30. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine.
Camus A; Javoy-Agid F; Dubois A; Scatton B
Brain Res; 1986 Jun; 375(1):135-49. PubMed ID: 3719352
[TBL] [Abstract][Full Text] [Related]
31. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.
Köhler C; Fuxe K; Ross SB
Eur J Pharmacol; 1981 Jul; 72(4):397-402. PubMed ID: 7274333
[TBL] [Abstract][Full Text] [Related]
32. The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography.
Seeman P; Guan HC; Civelli O; Van Tol HH; Sunahara RK; Niznik HB
Eur J Pharmacol; 1992 Oct; 227(2):139-46. PubMed ID: 1358662
[TBL] [Abstract][Full Text] [Related]
33. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
Köhler C; Ogren SO; Haglund L; Angeby T
Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
[TBL] [Abstract][Full Text] [Related]
34. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
List SJ; Seeman P
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
[TBL] [Abstract][Full Text] [Related]
35. Studies on the mechanism of action of substituted benzamide drugs.
Köhler C; Ogren SO; Fuxe K
Acta Psychiatr Scand Suppl; 1984; 311():125-37. PubMed ID: 6142588
[TBL] [Abstract][Full Text] [Related]
36. Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.
Köhler C; Radesäter AC
Neurosci Lett; 1986 May; 66(1):85-90. PubMed ID: 2940480
[TBL] [Abstract][Full Text] [Related]
37. The effect of acute kainic acid treatment on dopamine D2 receptors in rat brain.
Ridd MJ; Kitchen I; Fosbraey P
Neurosci Res; 1998 Mar; 30(3):201-11. PubMed ID: 9593330
[TBL] [Abstract][Full Text] [Related]
38. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
39. Interaction of (+)- and (-)-3-PPP with the dopamine receptor in the anterior pituitary gland.
Mikuni M; Gudelsky GA; Simonovic M; Meltzer HY
Life Sci; 1984 Jan; 34(3):239-46. PubMed ID: 6694521
[TBL] [Abstract][Full Text] [Related]
40. N-fluoroalkylated and N-alkylated analogues of the dopaminergic D-2 receptor antagonist raclopride.
Lannoye GS; Moerlein SM; Parkinson D; Welch MJ
J Med Chem; 1990 Sep; 33(9):2430-7. PubMed ID: 2391685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
